A randomized cross over trial exploring the Sleep Revolution diagnostic and therapeutic pathway in patients with obstructive sleep apnea

Directorate-General for Research and Innovation0 个研究点目标入组 1,000 人开始时间: 2024年2月23日最近更新: 2024年4月15日

适应症

试验速览

暂无简介。

•Main Inclusion Criteria:
•1. Referral to the sleep center due to suspected obstructive sleep apnea as the main question for evaluation
•2. Male or female aged 18 years and above
•3. Willing and able to provide written informed consent
•4. Willing and able to comply with the study design schedule and other requirements (e.g. no long-term travel conflicting with the planned visits throughout the study)

•Main Exclusion Criteria:
•1. Any ongoing treatment for OSA or central sleep apnea (CSA)
•2. Known significant hypercapnic respiratory failure due to chronic obstructive pulmonary disease or other respiratory condition
•3. Any other clinically determined contraindication for PAP treatment
•4. Patients participating in any type of weight loss treatment program
•5. Unstable congestive heart failure or angina pectoris
•6. Any other condition – to the judgement of the investigator – which potentially may jeopardize the completion of the study according to protocol
•7. History of alcohol or drug abuse during the last year, substance use disorder at screening

发起方

Directorate-General for Research and Innovation